Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
NCT02704390
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG:
ORADUR®-Methylphenidate
Sponsor
Orient Pharma Co., Ltd.
Collaborators
[object Object]